Sustainable Agriculture
ORBILLION
Scaleable, sustainable, cultivated beef
Founded:
2020
Located
San Francisco, United States
We invested
Series A
EARTH-FIRST VISION
Orbillion Bio, Inc. is a B2B cultivated meat technology company on a mission to create sustainable, nutritious, and premium beef at price parity with conventional meat. Focused on the global ground beef market, Orbillion has developed a breakthrough algorithm that optimizes production scaling, making high-quality, cost-effective cultivated beef a reality.
THE PROBLEM
The beef industry faces a pivotal challenge, balancing profit with mounting environmental and ethical costs. Cows are major emitters—not only through methane but also due to inefficiency. Producing one calorie of beef requires about 100 calories of feed, according to the World Resources Institute. With the global population nearing 10 billion by 2050, rising meat demand risks escalating environmental degradation, animal suffering, and health risks.
Cultivated meat offers a promising alternative, allowing people to enjoy meat without ethical compromise. This advancement marks a major step in our food history, aligning nourishment with a commitment to sustainability.
SOLUTIONS
Orbillion Bio is transforming cultivated meat production with its groundbreaking Orbiscale platform, designed to achieve price parity with conventional beef while cutting CAPEX by 40%. Leveraging a first-of-its-kind predictive data model and simulation algorithm, Orbillion optimizes key media parameters—such as pH, glucose, salts, and vitamins—to ensure mammalian cells scale efficiently under ideal conditions.
By prioritizing “bioware” over traditional bioreactors, Orbillion utilizes advanced computational models to refine cell lines and growth media. This innovative approach accelerates production, reduces costs, and brings cultivated meat closer to matching the affordability and accessibility of conventional meat products.
THEIR DNAs
The Orbillion Bio team brings unparalleled expertise to revolutionize cultivated meat. CEO Patricia, with a PhD in Biotechnology and postdoctoral work at UC Berkeley, has deep experience in sustainable food systems and bioprocess scaling from her leadership role at Boehringer Ingelheim. COO Samet S. Yildirim, former Head of Global Technology & Innovation at Boehringer Ingelheim, adds over a decade of biopharma innovation expertise. The team is guided by an advisory board including biotech leaders from UC Berkeley, UCLA, Henz and Pfizer. They are backed by investors like Y Combinator and Metaplanet,...